Delivery Order SPE2DB22D2103-SPE2DB24FR9KR

Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $6,322.56 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" with a completion date of May 21, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,241.34 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which runs through June 2024, is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML." Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, is providing these products to support DLA Troop Support Medical's mission to procure...
The U.S. Defense Logistics Agency (DLA) awarded a $3,687.28 firm-fixed-price delivery order contract to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is to provide the product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,053.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. This delivery order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,541.53 firm fixed-price delivery order contract is for the supply of a medical product described as "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML." The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,986.80 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4564668271 ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, with a completion date of May 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the supply of 4564654078 ! ZEPBOUND 10 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $3,261.31 delivery order contract has a completion date of May 21, 2024 and is a firm fixed price instrument. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $1,388.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on May 13, 2024. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,053.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564731155 ! ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This contract has an ultimate completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,337.99 for the supply of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML". The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 2, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR9KR
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $15,271.60 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and has a completion date of May 30, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the DLA's mission of providing logistics and technical services to the U.S. Armed Forces and other government agencies. The contract has a firm fixed price pricing type and does not utilize any set-aside designations.

Generated 8/28/24, 11:09 AM